Open Letter: Cellebrite should not go public without demonstrating human rights compliance
We... have published this open letter to the U.S. Securities and Exchange Commission (the SEC), NASDAQ, and other relevant stakeholders in Cellebrite’s bid to go public. We are calling on the parties to halt this deal until Cellebrite demonstrates that it has taken sufficient measures to comply with human rights...
[Cellebrite] continues selling its products to repressive regimes... In its draft registration statement... Cellebrite also notes the risks caused by its past transactions with the governments of Hong Kong, Russia, and Bangladesh... However, Cellebrite omits to disclose a number of other reported transactions that carry human rights risks... Cellebrite failed to disclose whether it conducted an investigation or due diligence into other customers... Cellebrite claims that it has a human rights compliance system, without providing further details...
[T]he undersigned civil society organizations and individuals [recommend]:
To SEC:
- Decline to approve Cellebrite’s draft Form F-4 unless it sufficiently addresses the lack of safeguards that led to the sale, support for, and continuous use of Cellebrite’s technology by human rights violating regimes...
To NASDAQ:
- Decline to approve the listing... unless Cellebrite demonstrates that its human rights compliance system is robust and transparent enough...
To [TWC Tech Holdings II Corp., a special-purpose acquisition company planning to merge with Cellebrite]:
- Delay the closing of the merger until Cellebrite demonstrates that its human rights compliance system is robust and transparent enough...
To SPAC Shareholders:
- ... Vote against the merger and redeem your SPAC shares unless Cellebrite demonstrates that its human rights compliance system is robust and transparent enough...